AMAG Pharmaceuticals Stock Price

0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
AMAG Pharmaceuticals Inc AMAG NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 13.75 19:00:00
Open Price Low Price High Price Close Price Previous Close
13.75 13.75
Bid Price Ask Price Spread News
13.04 13.90 0.86 - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 13.75 USD

AMAG Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 477.47M 34.73M 16.76M $ 327.75M $ -246.34M -13.69 -2.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

AMAG Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AMAG Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month13.7113.7613.610113.721,622,9250.040.29%
3 Months9.9013.778.6213.272,006,8813.8538.89%
6 Months7.7013.776.6412.171,114,5586.0578.57%
1 Year10.6913.774.4110.94870,5963.0628.62%
3 Years14.0026.104.4113.94844,583-0.25-1.79%
5 Years26.7236.8254.4117.71893,534-12.97-48.54%

AMAG Pharmaceuticals Description

AMAG Pharmaceuticals Inc primarily uses its nanoparticle technology to develop therapeutic compounds to treat anemia in patients suffering from chronic kidney disease, as well as imaging agents that assist in identifying cancerous tumors. The company recently received Food and Drug Administration approval for Feraheme, a novel iron replacement drug for CKD patients suffering from anemia, and also offers GastroMARK, an imaging aid used with magnetic resonance imaging. Most of the revenues are generated through the sale of Feraheme and Makena which is a hydroxyprogesterone caproate injection.

Your Recent History
AMAG Pharm..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.